03.01.2013 Views

scientific program • symposia - American Society for Reproductive ...

scientific program • symposia - American Society for Reproductive ...

scientific program • symposia - American Society for Reproductive ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

SCIENTIFIC PROGRAM <strong>•</strong> SYMPOSIA<br />

Tuesday, October 18, 2011 11:15 am – 1:00 pm<br />

Symposium<br />

THE ART OF MAKING ART<br />

Presented by the Association of <strong>Reproductive</strong> Managers Professional Group<br />

Kira Copperman, L.M.S.W. (Chair)<br />

KBC Consulting<br />

Jackie Meyers-Thompson<br />

J.D. Thompson Communications/Coppock-Meyers Public Relations<br />

Needs Assessment<br />

Technology moves as fast in the field of marketing and<br />

communication as it does in medicine. With the advent<br />

of social media, designer radio and Internet-based referral<br />

<strong>program</strong>s, what does your practice need to know about<br />

achieving the right mix of accessibility, transparency and<br />

communication, all the while maintaining a positive profile<br />

and patient privacy?<br />

Many practices are also trying to determine how to<br />

effectively spend their marketing dollars and how to<br />

measure the impact of those ef<strong>for</strong>ts. The ARM member<br />

survey results have consistently identified the need <strong>for</strong><br />

practical in<strong>for</strong>mation about marketing from practice<br />

managers, administrators, physician managers and nurses.<br />

Room 224 C/D<br />

72<br />

Learning Objectives<br />

At the conclusion of this session, participants should be able<br />

to:<br />

1. Identify at least three different approaches to marketing<br />

a reproductive medicine practice now.<br />

2. Formulate a budget <strong>for</strong> marketing and determine how to<br />

measure the impact of a campaign.<br />

ACGME COMPETENCY<br />

Systems-based Practice<br />

TEST QUESTION:<br />

After participating in this session, I will do the following in my<br />

practice:<br />

A. Work without a marketing plan or budget.<br />

B. Create an up-to-date marketing plan that is within my<br />

budget and determine an effective way to measure the<br />

impact.<br />

C. Have a marketing plan but not measure impact.<br />

D. Spend all of my marketing dollars in an online campaign.<br />

E. Not applicable to my area of practice.<br />

Tuesday, October 18, 2011 11:15 am – 1:00 pm<br />

Symposium<br />

Room 224 E/F<br />

WHEN LEGISLATION ENDANGERS YOUR PATIENT CARE -<br />

FIGHTING “PERSONHOOD” BILLS IN THE STATES<br />

Sean Tipton (Chair)<br />

ASRM Office of Public Affairs<br />

Andrew A. Toledo, M.D.<br />

<strong>Reproductive</strong> Biology Associates<br />

Stephanie K. Dahl, M.D.<br />

MeritCare <strong>Reproductive</strong> Medicine<br />

Barbara L. Collura<br />

RESOLVE<br />

Needs Assessment and Description<br />

State legislatures throughout the country have seen ef<strong>for</strong>ts<br />

to establish legal personhood beginning “at any stage of<br />

development.” What would such legislation mean to your<br />

ART practice, and how can you fight against it? Join this<br />

panel discussion to learn how your colleagues from around<br />

the country have fought against these laws.<br />

Learning Objectives<br />

At the conclusion of this session, participants should be able<br />

to:<br />

1. Describe the potential impact of so-called personhood<br />

legislation.<br />

2. Identify tools to fight its passage.<br />

ACGME COMPETENCY<br />

Systems-based Practice<br />

TEST QUESTION:<br />

Personhood legislation<br />

A. Is a passing trend in the political arena.<br />

B. Is consistently defined in each state.<br />

C. Has significant potential impact on ART practice.<br />

D. Has already passed in several states.<br />

Tuesday, October 18, 2011 11:15 am – 1:00 pm<br />

Contraception Day Case Presentation/Panel Symposium<br />

OBESITY AND CONTRACEPTION<br />

Alison B. Edelman, M.D. (Chair)<br />

Oregon Health & Science University<br />

Bliss E. Kaneshiro, M.D., M.P.H.<br />

Oregon Health & Science University<br />

Needs Assessment and Description<br />

Women and healthcare providers rely heavily on contraceptive<br />

methods not only <strong>for</strong> the prevention of pregnancy, but also <strong>for</strong><br />

the protection, management, or treatment of many diseases<br />

and conditions. As the obesity epidemic continues to expand, it<br />

is important to understand how contraception and obesity might<br />

interact. Using a combination of didactics, clinical cases, and a<br />

panel discussion, this interactive session will address issues pertaining<br />

to obesity and contraception including but not limited to the safety<br />

and efficacy of contraception in obese women and the effect of<br />

contraceptive use on a woman’s weight.<br />

Learning Objectives<br />

At the conclusion of this session, participants should be able to:<br />

1. Discuss the impact of hormonal contraception on<br />

Room 230 A/B<br />

baseline weight and how to counsel women regarding<br />

this concern.<br />

2. Describe the current evidence regarding the impact of<br />

obesity on contraceptive efficacy.<br />

3. Review the current prescribing recommendations <strong>for</strong><br />

contraception in obese women, those who are postbariatric<br />

surgery, and those with additional comorbidities.<br />

ACGME COMPETENCY<br />

Medical Knowledge, Patient Care<br />

TEST QUESTION:<br />

A 30-year-old obese female patient is requesting contraception and is<br />

concerned about further weight gain. After participating in this session,<br />

in my practice, I will counsel patients that:<br />

A. Medroxyprogesterone acetate has been conclusively linked to a<br />

10 lb weight gain in the first year of use.<br />

B. Combined oral contraceptives have not been proven to cause a<br />

weight gain.<br />

C. Obese women at any age should not use combined oral<br />

contraceptives.<br />

D. Not applicable to my area of practice.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!